# Interparfums Inc: Form 10-Q for the period ended Sep 30, 2009

- Company: [Interparfums Inc](/companies/ipar.md) (CIK 822663)
- Form: 10-Q
- Filed: 2009-11-09
- Accepted by EDGAR: Nov 9, 2009, 16:32 ET
- Period: 2009-09-30
- Accession: 0001144204-09-057484
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/822663/000114420409057484/v164888_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/822663/000114420409057484/

## Management's discussion and analysis

As filed, 46,410 characters.

### Forward Looking Information

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will" and "would" or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Inter Parfums' annual report on Form 10-K for the fiscal year ended December 31, 2008 and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

### Overview

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Our prestige fragrance products are produced and marketed by our European operations through our 75% owned subsidiary in Paris, Inter Parfums, S.A., which is also a publicly traded company as 25% of Inter Parfums, S.A. shares trade on the Euronext. Prestige cosmetics and prestige skin care products currently represent less than 3% of consolidated net sales.

We produce and distribute our prestige products primarily under license agreements with brand owners and European based prestige product sales represented 89% and 88% of net sales for the nine months ended September 30, 2009 and 2008, respectively. We have built a portfolio of brands, which include *Burberry, Lanvin, Van Cleef & Arpels, Jimmy Choo, Paul Smith, S.T. Dupont* and *Nickel* whose products are distributed in over 120 countries around the world. Burberry is our most significant license; sales of Burberry products represented 58% and 56% of net sales for the nine months ended September 30, 2009 and 2008, respectively.

In September 2009, by mutual consent as a result of unsatisfactory commercial development, we agreed to an early termination of our license agreement with Quiksilver. The termination will take effect on June 30, 2010 and is not expected to have any material effect on our consolidated financial statements.

Our specialty retail and mass-market fragrance and fragrance related products are marketed through our United States operations and represented 11% and 12% of net sales for the nine months ended September 30, 2009 and 2008, respectively. These products are sold under trademarks owned by us or pursuant to license or other agreements with the owners of the *Gap, Banana Republic, New York & Company, Brooks Brothers, bebe* and *Jordache* trademarks.

Historically, seasonality has not been a major factor for our Company. However, with the commencement of operations in 2007 of our four majority-owned European distribution subsidiaries and direct to retailer shipments of our specialty retail product lines, sales are more concentrated in the second half of the year.

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses or out-right acquisitions of brands. Second, we grow through the introduction of new products and supporting new and established products through advertising, merchandising and sampling as well as phasing out existing products that no longer meet the needs of our consumers. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers which manufacture the finished good for us and ship it back to our distribution center.

As with any business, many aspects of our operations are subject to influences outside our control. These factors include the effect of the current financial crisis and therefore the potential for further deterioration in consumer spending and consumer debt levels, as well as the continued availability of favorable credit sources and capital market conditions in general. The recent economic challenges and uncertainties in a number of countries where we do business, including the United States, have impacted our business. This financial crisis is global in scale and has negatively affected consumer demand, which is having an adverse impact on our distributors and our retail customers. These events have led distributors and retailers to carry less inventory than usual and have resulted in changes in their ordering patterns for the products that we sell. Although some signs of a recovery have become apparent with improving sales trends, the impact of this financial crisis has been challenging for us thus far this year and is expected to continue to be challenging for the remainder of 2009.

We have reviewed our plans and have taken actions to mitigate the impact of these conditions. We have adjusted, and we are continuing to adjust our advertising and promotional budgets to align our spending with anticipated sales. In addition, we have implemented cost saving initiatives to right size our staff in an effort to maintain long-term profitable growth. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. While our business strategies are designed to strengthen our Company over the long-term, we believe the uncertainty about future market conditions, consumer spending patterns and the financial strength of some of our customers could negatively affect our net sales and operating results.

In addition to the ongoing global financial crisis, our reported net sales in comparison to the corresponding periods of the prior year have been negatively impacted by changes in foreign currency exchange rates. A strong U.S. dollar has an adverse impact on our net sales, as a substantial portion of sales of our European operations are denominated in euro.

### Recent Important Events

### Jimmy Choo

In October 2009, we entered into an exclusive worldwide license agreement with J Choo Limited for the creation, development and distribution of fragrances under the Jimmy Choo brand. Our rights under such license agreement, which runs through 2022, are subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry. Plans call for our first Jimmy Choo fragrance launch in late 2010 or in 2011.

### bebe Stores, Inc.

In July 2008, we entered into an exclusive six year worldwide agreement with bebe Stores, Inc. under which we design, manufacture and supply fragrance, bath and body products and color cosmetics for company-owned bebe stores in the United States and Canada as well as select specialty and department stores worldwide.

### Gap and Banana Republic International

In April 2008, we expanded our current relationship with Gap Inc. with the signing of a licensing agreement for international distribution of personal care products through Gap and Banana Republic stores as well as select specialty and department stores outside the United States, including duty-free and other travel related retailers. The agreement is effective through December 31, 2011.

### Discussion of Critical Accounting Policies

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

The judgments used by management in applying critical accounting policies could be affected by a further and prolonged general deterioration in the economic environment, which could negatively influence future financial results and availability of continued financing. Specifically, subsequent evaluations of our accounts receivables, inventories, and deferred tax assets in light of the factors then prevailing, could result in significant changes in our allowance and reserve accounts in future periods which in turn could generate significant additional charges. Similarly, the valuation of certain intangible assets could be negatively impacted by prolonged and severely depressed market conditions thus leading to the recognition of impairment losses. The following is a brief discussion of the more critical accounting policies that we employ.

### Revenue Recognition

We sell our products to department stores, perfumeries, specialty retailers, mass-market retailers, supermarkets and domestic and international wholesalers and distributors. Sales of such products by our domestic subsidiaries are denominated in U.S. dollars and sales of such products by our foreign subsidiaries are primarily denominated in either Euros or U.S. dollars. Accounts receivable reflect the granting of credit to these customers. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, trade discounts and allowances.

### Sales Returns

Generally, we do not permit customers to return their unsold products. However, on a case-by-case basis we occasionally allow customer returns. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

### Promotional Allowances

We have various performance-based arrangements with certain retailers. These arrangements primarily allow customers to take deductions against amounts owed to us for product purchases. The costs that our Company incurs for performance-based arrangements, shelf replacement costs and slotting fees are netted against revenues on our Company’s consolidated statement of income. Estimated accruals for promotions and advertising programs are recorded in the period in which the related revenue is recognized. We review and revise the estimated accruals for the projected costs for these promotions. Actual costs incurred may differ significantly, either favorably or unfavorably, from estimates if factors such as the level and success of the retailers’ programs or other conditions differ from our expectations.

### Inventories

Inventories are stated at the lower of cost or market value. Cost is principally determined by the first-in, first-out method. We record adjustments to the cost of inventories based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual requirements if future economic conditions or competitive conditions differ from our expectations.

### Equipment and Other Long-Lived Assets

Equipment, which includes tools and molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

We evaluate goodwill and indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more likely than not (i) reduce the fair value of the reporting unit below its fair value or (ii) indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. Impairment of goodwill is evaluated using a two step process. The first step involves a comparison of the estimated fair value of the reporting unit to the carrying value of that unit. If the carrying value of the reporting unit exceeds the fair value of the reporting unit, the second step of the process involves comparison of the implied fair value of goodwill (based on industry purchase and sale transaction data) with its carrying value. If the carrying value of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized as an amount equal to the excess. For indefinite-lived intangible assets, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, impairment is recorded.

Goodwill relates to our Nickel skin care business, which is primarily a component of our European operations. Testing goodwill for impairment requires us to estimate the fair value of the reporting unit using significant estimates and assumptions. The assumptions we make will impact the outcome and ultimate results of the testing. In making our assumptions and estimates, we use industry accepted valuation models and set criteria that are reviewed and approved by management and, in certain instances, we engage third party valuation specialists to advise us. The first step of our goodwill impairment evaluation has given rise to potential impairment indicators and, as a result of continued sales declines, we test for impairment of goodwill on a quarterly basis. We have measured fair value of goodwill as a multiple of sales applied to the average of 2008 actual sales and projected sales for 2009 and 2010, which we believe is representative of the current state of the reporting unit. We expect Nickel brand sales to decline approximately 5% in 2009 as the global economic crisis continues, and we expect Nickel brand sales to increase 5% in 2010 as the result of new product launches in combination with an expected economic recovery. In estimating future sales, we use our internal budgets developed based on recent sales data for existing products and planned timing of new product launches. The sales multiple is based on a third party financial institution study of sales multiples for all transactions in the skin care, perfume and cosmetic sectors during the past four years. At current exchange rates, if average sales for the reporting unit decreased 10% we would incur a goodwill impairment charge of $1.0 million.

To determine fair value of indefinite-lived intangible assets, we use an income approach, including the relief-from-royalty method. This method assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. The relief-from-royalty calculations require us to make a number of assumptions and estimates concerning future sales levels, market royalty rates, future tax rates and discount rates. We use this method to determine if an impairment charge is required relating to our Nickel brand trademarks. During the three month period ended June 30, 2009, an impairment charge relating to the Nickel trademark in the amount of $0.26 million was recorded. No additional impairment during the three months ended September 30, 2009 was needed. We assumed a market royalty rate of 6% and a discount rate of 9.5%. The following table presents the impact a change in the following significant assumptions would have had on our impairment charge recognized at June 30, 2009 assuming all other assumptions remained constant:

*In thousands*

|  | Change | Increase (decrease) to impairment charge |
| --- | ---: | ---: |
| Weighted average cost of capital | +10% | $(181) |
| Weighted average cost of capital | -10% | $226 |
| Future sales levels | +10% | $264 |
| Future sales levels | -10% | $(264) |

The fair values used in our evaluations are also estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.5%. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. We believe that the assumptions that we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our indefinite-lived assets other than the Nickel trademarks referred to above. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our intangible assets subject to amortization. In those cases where we determine that the useful life of long-lived assets should be shortened, we would depreciate the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense.

In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3 (formerly paragraph 11 of SFAS 142). The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. “Any legal, regulatory, or contractual provisions that may limit the useful life”. The existence of a repurchase option in 2025 may limit the useful life of the Lanvin brand names and trademarks to the company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our company and their useful life would be considered to be indefinite.

With respect to the application of ASC topic 350-30-35-8 (formerly paragraph 13 of SFAS 142), the Lanvin brand names and trademarks would only have a finite life to our company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8 we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (Residual Value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.

### Derivatives

We account for derivative financial instruments in accordance with ASC topic 815 (formerly SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended), which establish accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. This topic also requires the recognition of all derivative instruments as either assets or liabilities on the balance sheet and that they are measured at fair value.

We currently use derivative financial instruments to hedge certain anticipated transactions and interest rates, as well as receivables denominated in foreign currencies. We do not utilize derivatives for trading or speculative purposes. Hedge effectiveness is documented, assessed and monitored by employees who are qualified to make such assessments and monitor the instruments. Variables that are external to us such as social, political and economic risks may have an impact on our hedging program and the results thereof.

### Income Taxes

Deferred income taxes are recognized for the tax consequences of temporary differences by applying enacted statutory tax rates applicable to future years to the difference between the financial statement carrying amounts and the tax bases of existing assets and liabilities. Tax benefits recognized are reduced by a valuation allowance where it is more likely than not that the benefits may not be realized.

### Results of Operations

### Three and Nine Months Ended September 30, 2009 as Compared to the Three and Nine Months Ended September 30, 2008

*(In millions)*

| Net sales | Three months ended September 30, 2009 | % Change | 2008 | Nine months ended September 30, 2009 | % Change | 2008 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| European based product sales | $104.0 | (4)% | $108.8 | $265.4 | (13)% | $303.3 |
| United States based product sales | 13.5 | (8)% | 14.7 | 31.2 | (27)% | 42.5 |
| Total net sales | $117.5 | (5)% | $123.5 | $296.6 | (14)% | $345.8 |

Net sales for the three months ended September 30, 2009 decreased 5% to $117.5 million, as compared to $123.5 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales decreased 6% for the period. Net sales for the nine months ended September 30, 2009 decreased 14% to $296.6 million, as compared to $345.8 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales decreased 11% for the period. The strength of the U.S. dollar relative to the euro during the first nine months of 2009 gave rise to the difference between constant dollar and reported net sales.

European based prestige product sales decreased 4% for the three months ended September 30, 2009 and 13% for the nine months ended September 30, 2009, as compared to the corresponding periods of the prior year. During the three month period ended September 30, 2009 we began to see a small recovery from the worldwide decline in consumer spending and the corresponding destocking of fragrance inventories by distributors and retailers experienced during the first half of the year. Our 4% decline in net sales for European operations and 5% decline in total sales are modest and consistent if not less than several of our peers. As was the case in the first half of 2009, the third quarter bar was set quite high last year when third quarter sales by European-based operations were 23% ahead of the same period one year earlier with much of the gain due to the rollout of Burberry *The Beat* for women. Nonetheless, in local currency, Burberry fragrance sales were 19% ahead for the current third quarter with sales of €48.0 million, compared to €40.3 million in the third quarter of 2008. For the first nine months of the 2009 Burberry fragrance sales were €125.7 million, as compared to and €128.0 million for the corresponding periods of the prior year. Lanvin, our second largest prestige brand, has proven somewhat resilient to the economic downturn with year-to-date sales virtually unchanged from last year in local currency. Quarterly fluctuations are the result of the timing the sell-in period of new product launches. For example, *Jeanne Lanvin* debuted in the fall of 2008, and *Lanvin L’Homme Sport* debuted this spring.

Despite the challenging economic environment in many parts of the world, certain territories continue to perform at satisfactory levels, notably, Western Europe, Asia and the Middle East.

There has been an active new product launch schedule throughout the year for European-based operations which began in January with the global rollout of the men’s version of Burberry *The Beat*. Also during the first quarter, we launched our Quiksilver signature fragrance for men. During the second quarter of 2009 we introduced an ST Dupont *Rose,* a fragrance for women and a Lanvin *L’Homme Sport* line, with tennis star, Rafael Nadal as its spokesperson. Paul Smith *Man* debuted in August and a limited edition, high-end women’s fragrance line for the Van Cleef & Arpels brand called *Collection Extraordinaire* was launched in September.

With respect to our United States specialty retail and mass-market products, net sales for the three and nine months ended September 30, 2009 declined 8% and 27%, respectively, to $13.5 million and $31.2 million, respectively, as compared to $14.7 million and $42.5 million for the corresponding periods of the prior year. In 2008, we expanded our relationship with Gap Inc. with the signing of a license agreement for international distribution of personal care products through Gap and Banana Republic stores as well as select specialty and department stores outside the United States, including duty-free and other travel related retailers. In early 2008, United States specialty retail product sales were climbing as a steady domestic business combined with a new and vibrant international business to drive sales growth. However, beginning in the fourth quarter of 2008, United States specialty retail product sales came under pressure. Our United States operations continue to feel the effects of the global financial crisis discussed above.

We disclosed in our last quarterly report, that new product launches together with existing distribution should stem the sales decline for our U.S. operations, and that was most certainly the case. In April 2009, Close, a new Gap fragrance was launched at approximately 550 Gap stores and roughly 175 Gap Body stores nationwide. International distribution is in process and is expected to reach 5,000 doors by 2009 year end. In August 2009, new fragrances, *Republic of Men* and *Republic of Women*, were launched at Banana Republic stores in North America with international distribution following shortly thereafter.

In November 2008, we shipped the Brooks Brothers *New York* collection for men and women to Brooks Brothers U.S. stores and international distribution is now underway. In addition, a new fragrance, *Black Fleece*, launched in the fall of 2009. Our signature bebe fragrance was unveiled at 212 bebe stores in the U.S. in August 2009, and over 300 Dillard stores in September 2009. Worldwide distribution began late in the third quarter of 2009. We also have plans to introduce a new fragrance for New York & Company during the fourth quarter of 2009.

Sales of our mass-market fragrance products have been in a decline for several years. The current global economic crisis has affected both our domestic and international customers. Credit availability has been curtailed and has resulted in continued sales declines. We have no plans to discontinue sales to this market, which aggregated approximately $4.2 million and $11.6 million for the three and nine months ended September 30, 2009, respectively, as compared to $5.6 million and $15.4 million for the corresponding periods of the prior year.

In addition, we are actively pursuing other new business opportunities. However, we cannot assure that any new licenses, acquisitions or specialty retail agreements will be consummated.

### INTER PARFUMS, INC. AND SUBSIDIARIES

*(In millions)*

| Gross margin | Three months ended September 30, 2009 | 2008 | Nine months ended September 30, 2009 | 2008 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $117.5 | $123.5 | $296.6 | $345.8 |
| Cost of sales | 50.4 | 56.2 | 125.7 | 148.4 |
| Gross margin | $67.1 | $67.3 | $170.9 | $197.4 |
| Gross margin as a percent of net sales | 57% | 55% | 58% | 57% |

Gross profit margin was 57% and 58% for the three and nine month periods ended September 30, 2009, respectively, as compared to 55% and 57% for the corresponding periods of the prior year. For the three and nine months ended September 30, 2009, gross margins included a benefit of approximately 193 basis points and 105 basis points, respectively, as a result of cash flow hedging activities entered into in late 2008 to take advantage of the effect a strong U.S. dollar relative to the euro has on our European based product sales to United States customers. Sales to these customers are denominated in dollars while our costs are incurred in euro. Additional fluctuations in gross margin results from product sales mix within individual lines of Company products. As reported in last years third quarter report, third quarter 2008 European based product sales included an unusually high level of gift sets which generate a lower gross margin than regular product.

Generally, we do not bill customers for shipping and handling costs and such costs, which aggregated $1.3 million and $3.7 million for the three and nine month periods ended September 30, 2009, respectively, as compared to $1.8 million and $4.9 million for the corresponding periods of the prior year, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to other companies which may include these expenses as a component of cost of goods sold.

*(In millions)*

| Selling, general and administrative expenses | Three months ended September 30, 2009 | 2008 | Nine months ended September 30, 2009 | 2008 |
| --- | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | $53.2 | $56.0 | $139.8 | $160.1 |
| Selling, general and administrative expenses as a percent of net sales | 45% | 45% | 47% | 46% |

Selling, general and administrative expenses decreased 5% and 13% for the three and nine month periods ended September 30, 2009, respectively, as compared to the corresponding periods of the prior year. As a percentage of sales, selling, general and administrative expenses were 45% and 47% of sales for the three and nine month periods ended September 30, 2009, respectively, as compared to 45% and 46% for the corresponding periods of the prior year.

Promotion and advertising included in selling, general and administrative expenses aggregated $18.4 million and $46.3 million for the three and nine month periods ended September 30, 2009, respectively, as compared to $19.7 million and $54.8 million for the corresponding periods of the prior year.

Promotion and advertising represented 15.6% of net sales for the nine months ended September 30, 2009, as compared to 15.9% of sales for the corresponding period of the prior year. Advertising expenditures in 2008 were high in support of the launch of Burberry, *The Beat* for women. As we anticipated lower sales volume in 2009 as compared to 2008, advertising expenditures were curtailed slightly. Royalty expense, included in selling, general and administrative expenses, aggregated $10.1 million and $26.5 million for the three and nine-month periods ended September 30, 2009, respectively, as compared to $9.8 million and $29.9 million for the corresponding periods of the prior year. The increase in royalty expense for the three-month period ended September 30, 2009 was a function of product sales mix.

Income from operations increased 23% to $13.9 million for the three months ended September 30, 2009, as compared to $11.3 million for the corresponding period of the prior year. Income from operations was $31.0 million for the nine month period ended September 30, 2009, as compared to $37.3 million for the corresponding period of the prior year. Operating margins were 11.8% and 10.5% of net sales for the three and nine month periods ended September 30, 2009, respectively, as compared to 9.1% and 10.8% for the corresponding periods of the prior year.

Interest expense aggregated $0.5 million and $2.2 million for the three and nine month periods ended September 30, 2009, respectively, as compared to $1.4 million and $2.9 million for the corresponding periods of the prior year. We use the credit lines available to us, as needed, to finance our working capital needs. Loans payable – banks and long-term debt including current maturities aggregated $42.1 million as of September 30, 2009, as compared to $73.2 million as of September 30, 2008. In addition, due to the changes in fair value of interest rate swaps, interest expense for the three months ended September 30, 2008 includes a charge of $0.4 million, as compared to a small benefit ($0.04 million) recorded for the three months ended September 30, 2009.

Foreign currency gains aggregated $0.9 million and $4.8 million for the three and nine-month ended September 30, 2009, respectively, as compared to losses of $0.1 million and $0.3 million for the corresponding periods of the prior year. We enter into foreign currency forward exchange contracts to manage exposure related to certain foreign currency commitments. As a result of the dramatic strengthening of the U.S. dollar during our fourth quarter ended December 31, 2008, we entered into foreign currency forward exchange contracts to hedge approximately 80% of our 2009 sales expected to be invoiced in U.S. dollars. As a result, for the three and nine months ended September 30, 2009, the Company recorded a gain of $1.5 million and $5.4 million, respectively, including amounts reclassified from Other Comprehensive Income into earnings relating to these contracts.

Our effective income tax rate was 33% and 34% for the three and nine months ended September 30, 2009, respectively, as compared to 23% and 34% for the corresponding periods of the prior year. Our effective tax rate generally approximates 35%. The effective tax rate differs from statutory rates primarily due to the effect of state and local taxes and tax rates in foreign jurisdictions which has declined slightly in 2009 as a result of the 2008 formation by Inter Parfums, SA, our 75% owned French subsidiary, of IP Suisse, who receives a favorable tax rate on a portion of Inter Parfums, S.A. taxable income. As of September 30, 2008, Nickel S.A., a wholly-owned subsidiary of Inter Parfums, S.A. was merged into Inter Parfums, S.A. As a result of the merger, the Company recognized the utilization of certain foreign operating loss carryforwards for which valuation allowances had previously been recorded. As a result, the tax provision in 2008 has been reduced by a benefit of approximately $0.7 million. No significant changes in tax rates were experienced nor were any expected in jurisdictions where we operate.

### INTER PARFUMS, INC. AND SUBSIDIARIES

| Net income and earnings per share (In thousands except per share data) | Three Months Ended September 30, 2009 | 2008 | Nine Months Ended September 30, 2009 | 2008 |
| --- | ---: | ---: | ---: | ---: |
| **Net income** | $9,611 | $7,879 | $22,620 | $23,506 |
| Less: Net income attributable to the noncontrolling interest | 2,349 | 1,691 | 5,704 | 4,838 |
| **Net income attributable to Inter Parfums, Inc.** | $7,262 | $6,188 | $16,916 | $18,668 |
| **Earnings per share:** |  |  |  |  |
| **Net income attributable to Inter Parfums, Inc. common shareholders:** |  |  |  |  |
| Basic | $0.24 | $0.20 | $0.56 | $0.61 |
| Diluted | $0.24 | $0.20 | $0.56 | $0.60 |
| **Weighted average number of shares outstanding:** |  |  |  |  |
| Basic | 30,097 | 30,632 | 30,061 | 30,660 |
| Diluted | 30,098 | 30,886 | 30,065 | 30,869 |

Net income increased 22% to $9.6 million for the three months ended September 30, 2009, as compared to $7.9 million for the corresponding period of the prior year. Net income decreased 4% to $22.6 million for the nine months ended September 30, 2009, as compared to $23.5 million for the corresponding period of the prior year.

Net income attributable to the noncontrolling interest aggregated 24% and 25% of net income for the three and nine months ended September 30, 2009, respectively, as compared to 21% for both the corresponding periods of the prior year. In 2008, losses from our 51% owned European distribution subsidiaries offset profits from our other 75% owned European subsidiaries.

Net income attributable to Inter Parfums, Inc. increased 17% to $7.3 million for the three months ended September 30, 2009, as compared to $6.2 million for the corresponding period of the prior year. Net income attributable to Inter Parfums, Inc. decreased 9% to $17.0 million for the nine months ended September 30, 2009, as compared to $18.7 million for the corresponding period of the prior year. Increased gross margins and foreign currency exchange gains from hedging activities, contributed to the growth in net income attributable to Inter Parfums, Inc. for the period.

Diluted earnings per share were $0.24 and $0.20 for the three months ended September 30, 2009 and 2008, respectively, and diluted earnings per share were $0.56 and $0.60 for the nine month periods ended September 30, 2009 and 2008, respectively. Weighted average shares outstanding aggregated 30.1 million for both the three and nine months ended September 30, 2009, respectively, as compared to 30.6 million and 30.7 million for the corresponding periods of the prior year. On a diluted basis, average shares outstanding were 30.1 million for both the three and nine months ended September 30, 2009, as compared to 30.9 million for both the three and nine months ended September 30, 2008, respectively. The decline in shares outstanding is primarily the result of shares repurchased pursuant to Board of Directors authorizations.

### Liquidity and Capital Resources

Our financial position remains strong. At September 30, 2009, working capital aggregated $195 million and we had a working capital ratio of almost 2.9 to 1. Cash and cash equivalents aggregated $58 million.

Cash provided by (used in) operating activities aggregated $33.6 million and ($41.1) million for the nine months ended September 30, 2009 and 2008, respectively. Working capital items provided $5 million in cash from operations in 2009 as compared to a use of $73 million in 2008. As of December 31, 2007 and continuing through September 30, 2008, we had a significant buildup of inventory to support a very aggressive launch schedule including Burberry, *The Beat* and new fragrance families for each of Lanvin, Van Cleef & Arpels, ST Dupont and Nickel. In terms of cash flows, for the nine month period ended September 30, 2009, inventories decreased $30.9 million. The global economic crisis has resulted in lower sales levels. Our inventory levels have been steadily declining since third quarter 2008 as we have made modifications to our sales projections to take into account the difficult environment. In terms of cash flow, accounts receivable increased $1.9 million for the nine months ended September 30, 2009, as extended payment terms to certain international distributors prevented further declines in accounts receivable during the period. In addition, in the 2009 period, accounts payable and accrued expenses decreased $24.5 million as our vendor obligations for the year end inventory buildup became due.

Cash flows used in investing activities in 2009 reflects payments of approximately $3.8 million for capital items. Our business is not capital intensive as we do not own any manufacturing facilities. We typically spend between $2.0 million and $3.0 million per year on tools and molds, depending on our new product development calendar. The balance of capital expenditures is for office fixtures, computer equipment and industrial equipment needed at our distribution centers. Capital expenditures in 2009 are expected to be in the range of $4.0 million to $4.5 million, considering our 2009 launch schedule.

Our short-term financing requirements are expected to be met by available cash on hand at September 30, 2009, cash generated by operations and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2009 consist of a $15.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $45.0 million in credit lines provided by a consortium of international financial institutions. As of September 30, 2009, short-term borrowings aggregated $10.0 million.

In 2007, we financed the acquisition of the worldwide rights to the Lanvin brand names and international trademarks and the license for the Van Cleef & Arpels brand and related trademarks by entering into five-year credit agreements. The long-term credit facilities provide for principal and interest to be repaid in 20 quarterly installments. As of September 30, 2009, total long-term debt including current maturities aggregated $32.1 million.

As of December 31, 2008, the Company’s Board of Directors authorized the repurchase of up to 1,031,863 shares of the Company’s common stock and through September 30, 2009, the Company repurchased 108,100 shares of its common stock at an average price of $5.84 per common share.

In December 2008, our Board of Directors authorized a continuation of our cash dividend of $0.133 per share, aggregating approximately $4.0 million per annum, payable $.033 per share on a quarterly basis. Our next cash dividend for 2009 will be paid on January 15, 2010 to shareholders of record on December 31, 2009. Dividends paid, including dividends paid once per year to minority shareholders of Inter Parfums, S.A., aggregated $4.7 million and $4.8 million for the nine months ended September 30, 2009 and 2008, respectively. The cash dividend for 2009 represents a small part of our cash position and is not expected to have any significant impact on our financial position.

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the nine months ended September 30, 2009.

### Contractual Obligations

The following table sets for a schedule of our contractual obligations as of December 31, 2008 over the periods indicated in the table, as well as our total contractual obligations ($ in thousands).

| Contractual Obligations | Payments due by period Total | Less than 1 year | Years 2-3 | Years 4-5 | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Long-Term Debt (2) | $41,000 | $13,400 | $23,000 | $4,600 |  |
| Capital Lease Obligations |  |  |  |  |  |
| Operating Leases | $27,100 | $7,100 | $13,000 | $4,300 | $2,700 |
| Purchase obligations(1) | $1,306,500 | $137,700 | $293,400 | $313,900 | $561,500 |
| Other Long-Term Liabilities Reflected on the Registrant's Balance Sheet under GAAP |  |  |  |  |  |
| Total | $1,374,600 | $158,200 | $329,400 | $322,800 | $564,200 |

(1) Consists of purchase commitments for advertising and promotional items, minimum royalty guarantees, including fixed or minimum obligations, and estimates of such obligations subject to variable price provisions. Future advertising commitments were estimated based on planned future sales for the license terms that were in effect at December 31, 2008, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

(2) Interest due on the Company’s long-term debt is payable $1.10 million, $0.70 million, $0.40 million and $0.07 million in 2009, 2010, 2011 and 2012, respectively.

## Market risk

As filed, 4,005 characters.

### General

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. Our French subsidiary primarily enters into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

### Foreign Exchange Risk Management

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a foreign currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Inter Parfums, S.A., our French subsidiary, whose functional currency is the Euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

As a result of the dramatic strengthening of the U.S. dollar during our fourth quarter ended December 31, 2008, we entered into foreign currency forward exchange contracts to hedge approximately 80% of our 2009 sales expected to be invoiced in U.S. dollars. Hedge effectiveness excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. At September 30, 2009, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $42.5 million and GB pounds 6.6 million which have varying maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

### Interest Rate Risk Management

We mitigate interest rate risk by continually monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt. We have entered into two (2) interest rate swaps to reduce exposure to rising variable interest rates. The first swap, entered into in 2004, effectively exchanged the variable interest rate of 0.6% above the three month EURIBOR to a variable rate based on the 12 month EURIBOR rate with a floor of 3.25% and a ceiling of 3.85%. As of December 31, 2008, the remaining balance owed pursuant to this facility was €1.6 million, which has been paid in full as of September 30, 2009. The second swap entered into in September 2007 on €22 million of debt, effectively exchanged the variable interest rate of 0.6% above the three month EURIBOR to a fixed rate of 4.42%. The remaining balance owed pursuant to this facility is €13.2 million. These derivative instruments are recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

## Controls and procedures

As filed, 1,303 characters.

### Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date our Company's disclosure controls and procedures were effective.

### Changes in Internal Controls

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

### Part II. Other Information

**Items 1, Legal Proceedings, 1A, Risk Factors, 2, Unregistered Sales of Equity Securities and Use of Proceeds, 3, Defaults Upon Senior Securities, 4, Submission of Matters to a Vote of Security Holders** and **5, Other Information**, are omitted as they are either not applicable or have been included in **Part I.**

Filed Nov 9, 2009.
Source: SEC EDGAR, the filing index for accession 0001144204-09-057484. Last ingested by Listed: Nov 4, 2026, 18:31 ET. No prices; not investment advice.
